Skip to content

Clinical trials

Phase 2 Digestive System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 2 Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20161
20171
20201
20211
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mirum Pharmaceuticals, Inc.2
Assistance Publique - Hôpitaux de Paris1
AusperBio Therapeutics Inc.1
Boston Scientific Corporation1
Eli Lilly and Company1
Inventiva Pharma1
Novo Nordisk A/S1
Vir Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases9
Liver Diseases5
Adenocarcinoma2
Carcinoma2
Digestive System Neoplasms2
Hepatitis2
Neoplasms2
Neoplasms by Histologic Type2
Neoplasms by Site2
Neoplasms, Glandular and Epithelial2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.